This inventor holds 2 USPTO granted patents, plus 4 CIPO patents. Top assignees: Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd., Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yandong Wang: Innovator in Ophthalmic Biotechnology
Introduction
Yandong Wang is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of ophthalmic biotechnology, particularly in the development of innovative compounds for treating eye conditions.
Latest Patents
Yandong Wang holds 1 patent for his invention titled "Salt form of isoquinolinone type compound as rock inhibitor and preparation method therefor." This patent discloses a salt form of an isoquinolinone type compound that acts as a ROCK protein kinase inhibitor. The invention also includes a preparation method and highlights the use of this compound in the development of medicaments for treating glaucoma or ocular hypertension.
Career Highlights
Throughout his career, Yandong Wang has worked with notable companies in the ophthalmic sector. He has been associated with Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. and Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. His work in these organizations has contributed to advancements in eye care and treatment options.
Collaborations
Yandong Wang has collaborated with esteemed colleagues, including Jian Ge and Yizhi Liu. These partnerships have fostered innovation and research in the field of ophthalmology.
Conclusion
Yandong Wang's contributions to ophthalmic biotechnology and his innovative patent demonstrate his commitment to improving eye health. His work continues to influence the development of effective treatments for glaucoma and ocular hypertension.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile